Want to continue viewing company data?

Sign up for exclusive competitive intelligence.
Company Data Subscription $329 per month (billed Annually)
Signup to View Free Sample

View up-to-date information on ICON Plc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.

Number of Deals

image for loader

Deal Value ($M)

Image for Loader
Gain insight into company strategy with premium access to M&A activity Gain insight into company strategy with premium access to M&A activity Find out more

Latest Deals

Announced Date Headline Deal Type Acquirers/Investors/Surviving Entity Issuer/Partner/Target
March 01, 2022 Berry Consultants Acquires ADDPLAN Clinical Trial Simulation Software from ICON Asset Transaction Berry Consultants LLC ICON Plc
August 05, 2021 Centessa Pharmaceuticals Plc Enters Phase II Clinical Trial Agreement with ICON Plc for imgatuzumab (GDCT0414093) Contract Service Agreement Centessa Pharmaceuticals Plc ICON Plc
August 02, 2021 Ascendis Pharma AS Enters Phase III Clinical Trial Agreement with PRA Health Sciences Inc for ACP-014 (GDCT0428798) Contract Service Agreement Ascendis Pharma AS PRA Health Sciences Inc
06 Apr 2021 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit Exercitation cillum velit Tempor
06 Apr 2021 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit Exercitation cillum velit Tempor
06 Apr 2021 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit Exercitation cillum velit Tempor
Explore the latest deals, partnerships, mergers & acquisitions when you subscribe Explore the latest deals, partnerships, mergers & acquisitions when you subscribe Subscribe
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer